Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9R5LC | — |
Expired product used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 22-month-old male patient who received HAV (Havrix) (batch number 9R5LC, expiry date 02-JAN-2024) for prophylaxis. On 11-MAR-2025, the patient received Havrix. On 11-MAR-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired product used). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAR-2025 The office manager called to reported that one of their new staff members administered an expired dose of Havrix to a patient, which led to an expired vaccine used. The reporter wanted to know do they have to call the patient to receive a new dose. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.